Rilpivirine
Rilpivirine
Rilpivirine (pronounced ril-pi-vi-rine) is an antiretroviral medication used in the treatment of HIV/AIDS. It is a non-nucleoside reverse transcriptase inhibitor (NNRTI) and is marketed under the brand names Edurant and Odefsey.
Etymology
The name "Rilpivirine" is derived from the chemical structure of the drug. The prefix "Ril-" is an abbreviation of the chemical group "aryl", "piv-" is derived from "piperidine", and "-irine" is a common suffix for NNRTIs.
Usage
Rilpivirine is used in combination with other antiretroviral medications to treat HIV-1 infection in adults and children who are at least 12 years old and weigh at least 35 kilograms. It is not a cure for HIV or AIDS, but it can help keep HIV under control and reduce the risk of developing illnesses associated with the disease.
Side Effects
Common side effects of Rilpivirine include depression, insomnia, headache, and rash. Serious side effects may include liver problems, mood changes, and changes in the immune system (immune reconstitution syndrome).
Related Terms
- Antiretroviral therapy
- Non-nucleoside reverse transcriptase inhibitors
- HIV/AIDS
- Immune reconstitution syndrome
External links
- Medical encyclopedia article on Rilpivirine
- Wikipedia's article - Rilpivirine
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski